Home › Funds › Amitell Capital Pte Ltd › THC
Amitell Capital Pte Ltd position in THC
TENET HEALTHCARE CORP · Health Care
Amitell Capital Pte Ltd reported holding 16,410 shares of THC (TENET HEALTHCARE CORP) in its Q2 2026 13F filing — a position valued at US$3.1M, representing 2.81% of its reported portfolio and ranking #13 among its reported holdings. Amitell Capital Pte Ltd has disclosed THC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Amitell Capital Pte Ltd's THC position evolved
Amitell Capital Pte Ltd first disclosed a stake in THC in Q3 2023 at 92,601 shares (US$6.1M). The position peaked in Q1 2024 at 114,374 shares, worth US$12.0M. Across 12 filings, Amitell Capital Pte Ltd increased the stake 2 time(s), trimmed it 7 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 16,410 shares valued at US$3.1M — a reduction of -15,750 shares quarter over quarter.. Notable position changes include a 56% increase in Q4 2023 (shares rose 39% over the following quarter), a 49% trim in Q2 2024 (shares rose 25% over the following quarter), a 49% trim in Q2 2026 (shares rose 37% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 92.60K | $6.10M | New |
| Q4 2023 | 144.76K | $10.94M | Add |
| Q1 2024 | 114.37K | $12.02M | Reduce |
| Q2 2024 | 58.37K | $7.76M | Reduce |
| Q3 2024 | 58.37K | $9.70M | Hold |
| Q4 2024 | 58.37K | $7.37M | Hold |
| Q1 2025 | 68.29K | $9.18M | Add |
| Q2 2025 | 53.14K | $9.35M | Reduce |
| Q3 2025 | 44.59K | $9.05M | Reduce |
| Q4 2025 | 35.01K | $6.96M | Reduce |
| Q1 2026 | 32.16K | $6.07M | Reduce |
| Q2 2026 | 16.41K | $3.07M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About THC and 13F data
THC (TENET HEALTHCARE CORP) is a Health Care company. 40 other funds we track also report a position in THC — the largest reported positions include Boston Partners (US$829.1M), GLENVIEW CAPITAL MANAGEMENT, LLC (US$418.2M), MANNING & NAPIER ADVISORS LLC (US$168.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding THC
- Boston Partners 4.43M sh · $829.06M · Q2 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 2.24M sh · $418.25M · Q2 2026
- MANNING & NAPIER ADVISORS LLC 901.64K sh · $168.76M · Q2 2026
- EMINENCE CAPITAL, LP 790.30K sh · $149.14M · Q1 2026
More on Amitell Capital Pte Ltd
FAQ
How long has Amitell Capital Pte Ltd held THC?
Amitell Capital Pte Ltd has disclosed THC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Amitell Capital Pte Ltd's current position in THC?
As of Q2 2026, Amitell Capital Pte Ltd holds 16.41K shares of THC (TENET HEALTHCARE CORP), valued at $3.07M, representing 2.81% of its reported portfolio and ranking #13.
Has Amitell Capital Pte Ltd been buying or selling THC?
In the latest 13F filing (Q2 2026), Amitell Capital Pte Ltd reduced its position in THC. The position peaked in Q1 2024 at 114.37K shares.
Which other funds hold THC?
Other major institutional holders of THC include Boston Partners, GLENVIEW CAPITAL MANAGEMENT, LLC, MANNING & NAPIER ADVISORS LLC, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.